The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticlesXiu-Chai Zheng, Xuan Zhang, Zhantao Li et al.|International Journal of Nanomedicine|2018Cited by 98
Effect of XlogP and Hansen Solubility Parameters on Small Molecule Modified Paclitaxel Anticancer Drug Conjugates Self-Assembled into NanoparticlesTing Zhong, Xuan Zhang, Yanli Hao et al.|Bioconjugate Chemistry|2018Cited by 27
Improving Solubility and Oral Bioavailability of Febuxostat by Polymer-Coated NanomatrixYi-Fan Yin, Xuan Zhang, Yang Guo et al.|AAPS PharmSciTech|2017Cited by 19
Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivoXiao-Chuan Duan, Xuan Zhang, Jingru Wang et al.|International Journal of Nanomedicine|2018Cited by 8